- Surgical management of non-invasive uterine clear cell carcinoma
-
Sugiyama T, Takeuchi S, Itamochi H
- KMID: 2413438
- J Gynecol Oncol.
- 2017 Jul;28(4):e55.
- doi: 10.3802/jgo.2017.28.e55
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- 9th Korea-Japan Gynecologic Cancer Joint Meeting
-
Ryu HS, Sugiyama T
- KMID: 2177506
- J Gynecol Oncol.
- 2012 Jan;23(1):3-4.
- doi: 10.3802/jgo.2012.23.1.3
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
-
Mabuchi S, Sugiyama T, Kimura T
- KMID: 2363325
- J Gynecol Oncol.
- 2016 May;27(3):e31.
- doi: 10.3802/jgo.2016.27.e31
Clear cell carcinoma (CCC) of the ovary is known to show poorer sensitivity to chemotherapeutic agents and to be associated with a worse prognosis than the more common serous adenocarcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Evidence for estrogen receptor expression during medullary bone formation and resorption in estrogen-treated male Japanese quails (Coturnix coturnix japonica)
-
Hiyama S, Sugiyama T, Kusuhara S, Uchida T
- KMID: 1389760
- J Vet Sci.
- 2012 Sep;13(3):223-227.
- doi: 10.4142/jvs.2012.13.3.223
The temporal expression of estrogen receptor (ER)-alpha and ER-beta mRNA was examined in male Japanese quails. Femurs of quails receiving 17beta-estradiol underwent RTPCR and histochemical analysis 1 to 15 days... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Endoscopic Treatment Plus Maintenance Dimethyl Sulfoxide Therapy Prolongs Recurrence-Free Time in Patients With Hunner Type Interstitial Cystitis: A Pilot Study
-
Otsuka A, Suzuki T, Matsushita Y, Watanabe H, Tamura K, Motoyama D, Ito T, Sugiyama T, Miyake H
- KMID: 2468719
- Int Neurourol J.
- 2019 Dec;23(4):327-333.
- doi: 10.5213/inj.1938110.055
PURPOSE: To evaluate whether hydrodistention with fulguration of Hunner lesions (HD/FUL) plus maintenance dimethyl sulfoxide (DMSO) therapy prolongs the recurrence-free time in patients with Hunner type interstitial cystitis (IC). METHODS: The... -
- CITED
-
- Close
- SHARE
-
- Close
- Extracorporeal Shock Wave Therapy and a New Assessment Tool for Intractable Wounds of the Limbs
-
Sugiyama T, Murakami H, Noguchi K, Kawano K, Shibata M, Shiba N
- KMID: 2540015
- J Wound Manag Res.
- 2023 Feb;19(1):21-27.
- doi: 10.22467/jwmr.2022.02124
Background: Extracorporeal shock wave therapy (ESWT) is indicated for intractable skin wounds and skin ulcers; however, assessing its efficacy for wounds at the periphery of the extremities may be difficult... -
- CITED
-
- Close
- SHARE
-
- Close
- Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial
-
Motohashi T, Yabuno A, Michimae H, Ohishi T, Nonaka M, Takano M, Nishio S, Fujiwara H, Keiichi K, Kondo E, Sugiyama T, Tabata T
- KMID: 2526299
- J Gynecol Oncol.
- 2021 Jan;32(1):e9.
- doi: 10.3802/jgo.2021.32.e9
Objective: The standard dose for pegylated liposomal doxorubicin (PLD) is 50 mg/m2 every 4 weeks. While 40 mg/m2 has recently been used in clinical practice, evidence supporting this use remains... -
- CITED
-
- Close
- SHARE
-
- Close
- The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG
-
Kondo E, Tabata T, Suzuki N, Aoki D, Yahata H, Kotera Y, Tokuyama O, Fujiwara K, Kimura E, Terauchi F, Sumi T, Okamoto A, Yaegashi N, Enomoto T, Sugiyama T
- KMID: 2512059
- J Gynecol Oncol.
- 2020 Nov;31(6):e94.
- doi: 10.3802/jgo.2020.31.e94
Objective: In this study we sought to investigate the clinical factors that affect postprogression survival (PPS) in patients with recurrent or persistent clear cell carcinoma (CCC). We utilized the JGOG3017/Gynecological Cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer
-
Matsuo K, Shimada M, Saito T, Takehara K, Tokunaga H, Watanabe Y, Todo Y, Morishige , Mikami M, Sugiyama T
- KMID: 2395238
- J Gynecol Oncol.
- 2018 Jan;29(1):e11.
- doi: 10.3802/jgo.2018.29.e11
OBJECTIVE: To examine the surgical-pathological predictors of para-aortic lymph node (PAN) metastasis at radical hysterectomy, and for PAN recurrence among women who did not undergo PAN dissection at radical hysterectomy. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer
-
Okamoto A, Kondo E, Nakamura T, Yanagida S, Hamanishi J, Harano K, Hasegawa K, Hirasawa T, Hori K, Komiyama S, Matsuura M, Nakai H, Nakamura H, Sakata J, Tabata T, Takehara K, Takekuma M, Yokoyama Y, Kase Y, Sumino S, Soeda J, Suri A, Aoki D, Sugiyama T
- KMID: 2526354
- J Gynecol Oncol.
- 2021 Mar;32(2):e16.
- doi: 10.3802/jgo.2021.32.e16
Objective: To evaluate the efficacy and safety of niraparib in Japanese women with heavily pretreated ovarian cancer. Methods: This Phase 2 open-label, single-arm study enrolled Japanese women with homologous recombination deficiency-positive... -
- CITED
-
- Close
- SHARE
-
- Close
- Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02)
-
Ohnishi S, Watari H, Kanno M, Ohba Y, Takeuchi S, Miyaji T, Oyamada S, Nomura E, Kato H, Sugiyama T, Asaka M, Sakuragi N, Yamaguchi , Uezono Y, Iwase S
- KMID: 2413215
- J Gynecol Oncol.
- 2017 Sep;28(5):e44.
- doi: 10.3802/jgo.2017.28.e44
OBJECTIVE: Rikkunshito, an herbal medicine, is widely prescribed in Japan for the treatment of anorexia and functional dyspepsia, and has been reported to recover reductions in food intake caused by... -
- CITED
-
- Close
- SHARE
-
- Close
